CD8A and neoplasm: The proportions of CD8 T cells, T cells follicular helper, Monocytes and Activated mast cells in the low RiskScore group were significantly higher than those in the high RiskScore group (Figure 4A), indicating that the low-risk patients had more strong immune ability against tumor cells.